Applied Therapeutics, Inc. - stock earnings
APLT Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 9, 2024 BeforeMarket | - / -0.1428000000 | - | - / 3.4 million | - |
APLT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -37.7 million USD | -667000 USD |
| 2023Q3 | -42.4 million USD | ? USD |
| 2023Q2 | -29.6 million USD | ? USD |
| 2023Q1 | -9.4 million USD | 10.7 million USD |
| 2022Q4 | -5.8 million USD | ? USD |
| 2022Q3 | -18.8 million USD | ? USD |
| 2022Q2 | -34.3 million USD | ? USD |
| 2022Q1 | -23.1 million USD | ? USD |
| 2021Q4 | -27.2 million USD | ? USD |
| 2021Q3 | -28.4 million USD | ? USD |
| 2021Q2 | -25.8 million USD | ? USD |
| 2021Q1 | -24.2 million USD | ? USD |
| 2020Q4 | -23.7 million USD | ? USD |
| 2020Q3 | -29.8 million USD | ? USD |
| 2020Q2 | -28.1 million USD | ? USD |
| 2020Q1 | -12.4 million USD | ? USD |
| 2019Q4 | -17.6 million USD | ? USD |
| 2019Q3 | -10.7 million USD | ? USD |
| 2019Q2 | -8.4 million USD | ? USD |
| 2019Q1 | -8.7 million USD | ? USD |
| 2018Q4 | -6.7 million USD | ? USD |
| 2018Q3 | -4.3 million USD | ? USD |
| 2018Q2 | -3.2 million USD | ? USD |
| 2018Q1 | -2.3 million USD | ? USD |
APLT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -119.8 million USD | 10.0 million USD |
| 2022 | -81.7 million USD | 10.7 million USD |
| 2021 | -104.6 million USD | ? USD |
| 2020 | -93.0 million USD | ? USD |
| 2019 | -45.4 million USD | ? USD |
| 2018 | -16.5 million USD | ? USD |
| 2017 | -4.3 million USD | ? USD |
APLT
Price: $4.71
52 week price:
Earnings Per Share: -1.42 USD
P/E Ratio: -2.42
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 546852
Market Capitalization: 657.6 million